PARKINSON DISEASE
Clinical trials for PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Parkinson's drug trial halted early: what happened with VENT-02?
Disease control TerminatedThis study tested an experimental drug called VENT-02 in 29 people with mild to moderate Parkinson's disease. The goal was to see if the drug is safe and how it affects inflammation in the body. Participants took the drug or a placebo twice a day for 28 days. The study was stoppe…
Matched conditions: PARKINSON DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated May 26, 2026 02:42 UTC
-
Exercise may tame Parkinson's inflammation, study hints
Disease control TerminatedThis study looked at whether a program of intensive physical activity could improve movement and reduce inflammation in people with Parkinson's disease. Researchers compared 30 patients who exercised with those who stayed sedentary, measuring changes in motor skills and blood mar…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Swallowing detector fails accuracy test, study halted
Diagnosis TerminatedThis study tested a new device (DDS) to see if it could accurately detect swallowing problems in people with conditions like stroke, Parkinson's disease, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray test. The study was stopped early be…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated May 26, 2026 02:46 UTC
-
Parkinson's walking study tests poles for better mobility
Symptom relief TerminatedThis study looked at whether using walking poles during an 8-week walking program can improve walking and daily activity in people with Parkinson's disease. Eleven participants wore activity trackers and had their walking measured before and after the program. The study was stopp…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Pacific Northwest University of Health Sciences • Aim: Symptom relief
Last updated May 26, 2026 02:55 UTC
-
Parkinson's OFF episode inhaler trial halted early
Symptom relief TerminatedThis study tested an inhaled medication called Staccato Apomorphine (AZ-009) to quickly relieve 'OFF' episodes in people with Parkinson's disease. OFF episodes are times when Parkinson's symptoms return between medication doses. The trial was terminated early and only enrolled 8 …
Matched conditions: PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC
-
Parkinson's drug safety trial halted early
Symptom relief TerminatedThis early-stage study tested a new drug called talineuren in 22 people with Parkinson's disease. The goal was to see if it is safe to give through a vein. The study was stopped early, and it focused on safety, not on curing the disease.
Matched conditions: PARKINSON DISEASE
Phase: PHASE1 • Sponsor: InnoMedica Schweiz AG • Aim: Symptom relief
Last updated May 26, 2026 02:47 UTC
-
Robot walker aims to help Parkinson's patients move better
Symptom relief TerminatedThis study tested whether a robotic gait trainer (G-EO System) is safe and helpful for people with Parkinson's disease who have trouble walking. Fifteen participants were enrolled to see if the device could improve mobility, function, and quality of life. The study was terminated…
Matched conditions: PARKINSON DISEASE
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated May 26, 2026 02:44 UTC
-
Parkinson's drug tested for apathy, but study stops early
Symptom relief TerminatedThis study looked at whether istradefylline, a drug already approved for motor symptoms in Parkinson's disease, could also improve apathy and motivation. Apathy is a common issue where people lose interest and drive. The study planned to follow 8 participants for 12 weeks, but it…
Matched conditions: PARKINSON DISEASE
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC